Live Breaking News & Updates on Per Fischer|Page 2

Stay updated with breaking news from Per fischer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MinervaX provides clinical and leadership update

/PRNewswire/ MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces. ....

United States , Al Iskandariyah , United Kingdom , South Africa , Bruxelles Capitale , Peter Patriarca , Jean Paul Prieels , Clement Lewin , Quantoom Bioscience , Ralf Clemens , Sanofi Pasteur , Petera Patriarca , Gerd Zettlmeissl , Prnewswire Minerva , American Academy Of Pediatrics , Affairs Immunization Policy For North America , Office Of Vaccines Research , Head Global Vaccines Development , World Vaccine Congress , Groupb Streptococcus , Biologics Consulting Group Inc , Division Of Viral Products , Danish Medicines Agency , Global Poliomyelitis Eradication Initiative , Wharton Business School , Centers For Disease ,

MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials

Share:
COPENHAGEN, Denmark, Dec. 15, 2020 /PRNewswire/ MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), announced today that it has raised an upsized EUR 47.4 million Series B financing. The round included new investors Sanofi Ventures, Wellington Partners, Adjuvant Capital, and Industrifonden, along with existing investors Novo Holdings REPAIR Impact Fund, Sunstone Life Science Ventures, and LF Investment. Proceeds will advance the clinical development of MinervaX s novel GBS vaccine through Phase II clinical trials, as well as manufacturing and regulatory preparation for Phase III.
Concurrent with the financing, Christopher Gagliardi from Sanofi Ventures, Karl Nägler from Wellington Partners, Kabeer Aziz from Adjuvant Capital and Bita Sehat from Industrifonden will join MinervaX s board of directors. ....

United States , New Zealand General , New Zealand , Christopher Gagliardi , Kabeer Aziz , Emmanuelle Coutanceau , Prnewswire Minerva , Lauritzen Foundation , Impact Fund , World Health Organization , Melinda Gates Foundation , Boston Scientific , Groupb Strep International , Groupb Streptococcus , International Finance Corporation , Lund University , United States Centers For Disease , Life Sciences , Groupb Strep , Novo Holdings , Wellington Partners , Adjuvant Capital , Sunstone Life Science Ventures , Sanofi Ventures , Bita Sehat , Per Fischer ,